Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$190.52 - $236.72 $3,810 - $4,734
20 Added 153.85%
33 $7,000
Q1 2024

Apr 19, 2024

SELL
$212.02 - $267.71 $636 - $803
-3 Reduced 18.75%
13 $2,000
Q4 2023

Jan 25, 2024

BUY
$222.59 - $267.94 $3,561 - $4,287
16 New
16 $4,000
Q4 2022

Jan 12, 2023

SELL
$252.44 - $306.72 $15,651 - $19,016
-62 Reduced 98.41%
1 $0
Q3 2022

Nov 08, 2022

BUY
$194.69 - $268.46 $194 - $268
1 Added 1.61%
63 $17,000
Q1 2022

May 06, 2022

SELL
$193.77 - $244.14 $5,038 - $6,347
-26 Reduced 29.55%
62 $13,000
Q4 2021

Feb 11, 2022

SELL
$223.92 - $287.77 $5,150 - $6,618
-23 Reduced 20.72%
88 $21,000
Q3 2021

Nov 10, 2021

BUY
$282.99 - $369.05 $2,546 - $3,321
9 Added 8.82%
111 $31,000
Q2 2021

Aug 02, 2021

BUY
$259.0 - $414.71 $5,439 - $8,708
21 Added 25.93%
102 $35,000
Q1 2021

May 07, 2021

BUY
$242.95 - $284.63 $4,616 - $5,407
19 Added 30.65%
81 $23,000
Q1 2019

Apr 26, 2019

SELL
$216.71 - $338.96 $4,550 - $7,118
-21 Reduced 25.3%
62 $15,000
Q4 2018

Feb 25, 2019

BUY
$278.5 - $352.75 $5,848 - $7,407
21 Added 33.87%
83 $25,000
Q2 2018

Aug 14, 2018

SELL
$257.52 - $306.91 $3,090 - $3,682
-12 Reduced 16.22%
62 $18,000
Q3 2017

Nov 14, 2017

BUY
$281.15 - $329.69 $20,805 - $24,397
74
74 $23,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $23B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Valley National Advisers Inc Portfolio

Follow Valley National Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Valley National Advisers Inc with notifications on news.